China National Center for Cardiovascular Diseases
Beijing, Beijing Municipality, 100037, China
NCT Number: NCT03068858
The SYNTAX score (SS) has been recommended by clinical guideline and appropriate use criteria for coronary revascularization (CR) to provide guidance on optimal treatment strategies for patients with stable coronary artery diseases (CAD). However, discrepancy in SS between angiographic core lab (ACL) and cardiologists has been found. Whether the misestimate will lead to inappropriate CR and whether a SS intervention will improve CR appropriateness in patients with stable CAD remain unknown.
Thus, our study aims at evaluating whether a real-time feedback from ACL rightafter the angiographies will improve CR appropriateness. A before-and-after controlled trial was designed. In the first period of time, stable CAD patients undergoing elective coronary angiographies with at least one coronary lesion stenosis ≥ 50% from one Chinese cardiac center will be continuously recruited as the control group. In the second period, eligible patients will be recruited continuously and a real-time SS category feedback from ACL rightafter the angiography will be given to the cardiologists. Appropriateness of treatment strategies in two groups will be analyzed to determine whether a real-time SS feedback can improve the treatment appropriateness. The appropriateness of treatment strategies will be adjudicated by Chinese version appropriate use criteria for CR.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Beijing, Beijing Municipality, 100037, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 month after study completion
Inappropriate rate will be adjudicated by Chinese appropriate use criteria for coronary revascularization.
Time frame: 1 month after study completion
Inappropriate rate of percutaneous coronary intervention (PCI) will be adjudicated by Chinese appropriate use criteria for coronary revascularization.
Time frame: 1 month after study completion
Inappropriate rate of coronary artery bypass graft (CABG) will be adjudicated by Chinese appropriate use criteria for coronary revascularization.
Time frame: 1 month after study completion
The proportion of patients who undergo percutaneous coronary intervention (PCI) among total patients
Time frame: 1 month after study completion
The proportion of patients who undergo coronary artery bypass graft (CABG) among total patients
China National Center for Cardiovascular Diseases
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06541132
Arterial Occlusive Diseases, Arteriosclerosis
Chongqing, Chongqing Municipality, China
View Trial DetailsNCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT03229941
Acute Kidney Injury, Acute Renal Failure
Little Rock, Arkansas, United States
View Trial DetailsNCT06520215
Coronary Revascularization
Bandung, West Java, Indonesia
View Trial Details